Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-08-04Clinical Trial Update: St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder. [Phase 2]
A Phase 2 trial comparing St. John's Wort to placebo in obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-26Clinical Trial Update: Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD) [Phase 3]
A Phase 3 trial reports tolerability and efficacy of high-dose escitalopram for obsessive-compulsive disorder. The study has completed.
-
FDA approval · 2006-07-24FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for fluvoxamine maleate, a generic formulation, manufactured by Upsher-Smith Laboratories.
-
FDA approval · 2006-07-24FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Apotex Corp)
FDA approved a supplemental ANDA for fluvoxamine maleate from Apotex Corp, enabling generic product availability.
-
FDA approval · 2006-05-04FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by Roerig. The approval updates the product's la…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.